The life sciences industry, particularly emerging biotechnology companies, is a major and growing employer and is vital to the overall economic health of New Jersey, responsible for nearly $36 billion in GDP, $2.4 billion in local and state tax revenues, and supporting over 242,000 jobs.
Exploring Cutting Edge Technologies and Global Clinical Trials of the Future.
Merck’s 3,600-employee Discovery, Pre-Clinical and Early Development group is cutting “less than 10 percent,” or between 300 and 360 jobs, from sites in North Wales, PA, Rahway, NJ and Kenilworth, NJ locations.
AbbVie has sent the rights to duvelisib back to Infinity, leading to another round of job cuts at the Cambridge, MA, company.
Fast-growing fish oil maker Sancilio & Co. — which plans to add 275 jobs over four years — has negotiated $3.8 million in job-creation subsidies from the state, county and city
The educational foundation of Massachusetts’ biopharma group MassBio recently delivered a sunny forecast for continued industry job growth, in the Bay State at least. MassBioEd is projecting a 6.7% increase in jobs in the three-year period ending May 2018,
